Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 200 /hr
Hire Harrison B.
United States
USD 200 /hr
Here to provide subject matter expertise in virology, immunology, and vaccinology study design
Profile Summary
Subject Matter Expertise
Services
Writing
Medical Writing,
Technical Writing,
General Proofreading & Editing
Research
Scientific and Technical Research,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
Work Experience
Board Member and Scientific Advisor
StrainSeekr
October 2023 - Present
Postdoctoral Scientist
UGA / Emory University
May 2023 - Present ![]()
Graduate Student
University of Georgia
2017 - 2023 ![]()
Post-Bac ORISE Fellow
Centers for Disease Control and Prevention
2016 - 2017 ![]()
Post-Bac ORISE Fellow
Plum Island Animal Disease Center
2015 - 2016 ![]()
Education
PhD (Infectious Diseases)
University of Georgia College of Veterinary Medicine
2017 - 2023 ![]()
BS Biology (College of Science)
Virginia Tech
2011 - 2015 ![]()
Certifications
- Certification details not provided.
Publications
PREPRINT
Z. Beau Reneer, Harrison C. Bergeron, Stephen Reynolds, Elena Thornhill-Wadolowski, Lan Feng, Marcin Bugno, Agnieszka D. Truax, Ralph A. Tripp (2023). mRNA Vaccines Encoding Influenza Virus Hemagglutinin (HA) Elicits Immunity in Mice from Influenza A Virus Challenge .
JOURNAL ARTICLE
Harrison C. Bergeron, Matthew R. Hansen, Ralph A. Tripp (2023). Interferons—Implications in the Immune Response to Respiratory Viruses . Microorganisms.
Harrison C. Bergeron, Jackelyn Murray, Aakash Arora, Ana M. Nuñez Castrejon, Rebecca M. DuBois, Larry J. Anderson, Lawrence M. Kauvar, Ralph A. Tripp (2023). Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein . Viruses.
Harrison C. Bergeron, Jackelyn Murray, Aakash Arora, Ana M. Nuñez Castrejon, Rebecca DuBois, Larry Anderson, Lawrence M. Kauvar, Ralph A. Tripp (2023). Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein . Viruses.
Harrison C. Bergeron, Lawrence M. Kauvar, Ralph A. Tripp (2023). Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response . Therapeutic Advances in Infectious Disease.
Bergeron, Harrison C., Murray, Jackelyn, Juarez, Maria G., Nangle, Samuel J., DuBois, Rebecca M., Tripp, Ralph A. (2023). Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine . Frontiers in Immunology.
Bergeron, Harrison C., Hansen, Matthew R., Tripp, Ralph A. (2023). Interferons-Implications in the Immune Response to Respiratory Viruses . Microorganisms.
Bergeron, Harrison C., Murray, Jackelyn, Arora, Aakash, Castrejon, Ana M. Nunez M., DuBois, Rebecca M., Anderson, Larry J., Kauvar, Lawrence M., Tripp, Ralph A. (2023). Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein . Viruses.
Thomas J. Powell, Andrea Jacobs, Jie Tang, Edwin Cardenas, Naveen Palath, Jennifer Daniels, James G. Boyd, Harrison C. Bergeron, Patricia A. Jorquera, Ralph A. Tripp (2022). Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge . Vaccines.
Thomas J. Powell, Andrea Jacobs, Jie Tang, Edwin Cardenas, Naveen Palath, Jennifer Daniels, James G. Boyd, Harrison C. Bergeron, Patricia A. Jorquera, Ralph A. Tripp (2022). Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge . Vaccines.
Harrison C. Bergeron, Ralph A. Tripp (2022). RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein . Viruses.
Harrison C. Bergeron, Zachary Beau Reneer, Aakash Arora, Stephen Reynolds, Tamas Nagy, Ralph A. Tripp (2022). Influenza B Virus (IBV) Immune-Mediated Disease in C57BL/6 Mice . Vaccines.
Harrison C. Bergeron, Zachary Beau Reneer, Aakash Arora, Stephen Reynolds, Tamas Nagy, Ralph A. Tripp (2022). Influenza B Virus (IBV) Immune-Mediated Disease in C57BL/6 Mice . Vaccines.
Jackelyn Murray, Harrison C. Bergeron, Les P. Jones, Zachary Beau Reener, David E. Martin, Fred D. Sancilio, Ralph A. Tripp (2022). Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication . Viruses.
Jackelyn Murray, Harrison C. Bergeron, Les P. Jones, Zachary Beau Reener, David Martin, Fred D. Sancilio, Ralph A. Tripp (2022). Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication . Viruses.
Harrison C. Bergeron(2022). Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV) . Expert Opinion on Investigational Drugs. 31. (1). p. 23--29. Informa {UK} Limited
Harrison C. Bergeron, Ralph A. Tripp (2022). Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV) . Expert Opinion on Investigational Drugs.
Harrison C. Bergeron, Ralph A. Tripp (2021). Immunopathology of RSV: An Updated Review . Viruses.
Harrison C. Bergeron, Ralph A. Tripp (2021). Immunopathology of RSV: An Updated Review . Viruses.
Harrison C. Bergeron, Jackelyn Murray, Ana M. Nuñez Castrejon, Rebecca M. DuBois, Ralph A. Tripp (2021). Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies . Viruses.
Harrison C. Bergeron, Jackelyn Murray, Ana M. Nuñez Castrejon, Rebecca DuBois, Ralph A. Tripp (2021). Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies . Viruses.
Harrison C. Bergeron and Ralph A. Tripp(2020). Emerging small and large molecule therapeutics for respiratory syncytial virus . Expert Opinion on Investigational Drugs. 29. (3). p. 285--294. Informa {UK} Limited
H. C. Bergeron, P. S. Glas, K. R. Schumann (2017). Diagnostic specificity of the African swine fever virus antibody detection enzyme‐linked immunosorbent assay in feral and domestic pigs in the United States . Transboundary and Emerging Diseases.
H. C. Bergeron and P. S. Glas and K. R. Schumann(2017). Diagnostic specificity of the African swine fever virus antibody detection enzyme‐linked immunosorbent assay in feral and domestic pigs in the United States . Transboundary and Emerging Diseases. 64. (6). p. 1665--1668. Wiley
REVIEW
Harrison C. Bergeron, Ralph A. Tripp(2022). RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein . Viruses. 14. (11). p. 2396. {MDPI} {AG}